AUSTIN, Texas (PRWEB) September 04, 2020
TeVido BioDevices (TeVido), a leader in regenerative medicine for repairing loss of pigmentation, today launched Boutique Testing Services for diagnosis of COVID-19.
Testing capacity is limited across the country. Many diagnostic laboratories are overwhelmed - causing long lead times for results. Yet many situations require a COVID-Negative test result performed within 72 hours of showing up. Employment requirements, travel, and elective surgeries are just a few examples. Unfortunately, these scenarios have low priority in the testing queue.
“As we spoke to our TruPigment™ partners,” said Laura Bosworth TeVido CEO, “we learned private clinics are struggling to meet the needs of their clients.”
TeVido will sign up a limited number of clinics for dedicated COVID-19 diagnostic testing. The concierge service turns around results quickly and reliably. Results are typically provided next business day when samples are delivered to TeVido before 10.30 a.m. We work closely with clinic staff to customize a schedule for picking up patient samples that fits the needs of a busy private practice. We provide a saliva sample collection kit that is easy to use and considered more comfortable for patients than traditional nasopharyngeal swabs.
Bosworth goes on to say, “By maintaining a small number of testing clients, we can meet their needs while continuing to work with TruPigment™ early adopters.”
The Company also announced the appointment of Christine Bulot, Ph.D. as Clinical Lab Director. An experienced microbiologist, Dr. Bulot has over 15 years’ successful lab experience and is certified by the American Board of Bioanalysis as a High Complexity Clinical Laboratory Director and by the College of American Pathologists as a Laboratory Inspector Team Lead.
TeVido leverages an existing FDA compliant facility, high complexity test equipment and strength in molecular biology to join the fight against COVID-19. TeVido performs SARS-CoV-2 diagnostic tests using a well-known laboratory technique called polymerase chain reaction or PCR, to determine if a patient has a current infection. PCR is generally considered the gold standard for testing. The cost for our test is competitive with others and often less expensive.
TruPigment™, TeVido’s lead product, enables physicians to provide skin cell transplants, to treat loss of skin color, without making costly investment in equipment and specialized skills.
About TeVido BioDevices: TeVido is a privately-held, commercial stage, Biotechnology Company addressing unmet needs in reconstructive and aesthetic procedures, utilizing a patient’s own living cells. TeVido’s state of the art facility is located in Austin, Texas where the Company is headquartered. The Company has invested several years and millions of dollars on research and development of TruPigment™ and has been the recipient of Small Business Innovation (SBIR) awards from the National Science Foundation and the National Cancer Institute. https://tevidobiodevices.com/covid-19-testing/
For More Information, please contact:
CEO TeVido BioDevices, Inc